VBI Vaccines Inc
F:LO9A

Watchlist Manager
VBI Vaccines Inc Logo
VBI Vaccines Inc
F:LO9A
Watchlist
Price: 0.0845 EUR Market Closed
Market Cap: 2m EUR

Net Margin
VBI Vaccines Inc

-892.9%
Current
-8 135%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-892.9%
=
Net Income
-84m
/
Revenue
9.4m

Net Margin Across Competitors

No Stocks Found

VBI Vaccines Inc
Glance View

Market Cap
2.1m EUR
Industry
Biotechnology

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The company is headquartered in Cambridge, Massachusetts and currently employs 149 full-time employees. The company went IPO on 2001-11-19. The firm develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The firm is focused on targeting and overcoming infectious diseases, including hepatitis B (HBV), COVID-19, and coronaviruses, and cytomegalovirus (CMV), as well as cancers including glioblastoma (GBM). Its PreHevbrio (Hepatitis B Vaccine [Recombinant]), which contains S, pre-S2, and pre-S1 HBV surface antigens and is an approved 3-antigen HBV vaccine for adults. Its Prophylactic candidates include VBI-2900, which is a coronavirus vaccine Program (VBI-2901, VBI-2902, VBI-2905); VBI-1501, which is prophylactic CMV vaccine candidate; VBI-2601, which is HBV Immunotherapeutic Candidate, and VBI-1901, which targets CMV proteins present in tumor cells. The firm is conducting the Phase I/IIa clinical study of GBM vaccine immunotherapeutic candidate VBI-1901.

LO9A Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-892.9%
=
Net Income
-84m
/
Revenue
9.4m
What is the Net Margin of VBI Vaccines Inc?

Based on VBI Vaccines Inc's most recent financial statements, the company has Net Margin of -892.9%.

Back to Top